Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Not yet recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Classical hematology 1

Conditions

Colorectal Neoplasms 2Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 1Hepatic Veno-Occlusive Disease 1Disease 1Chemical and Drug Induced Liver Injury 1Adenoma 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × S-Adenosylmethionine × 90 days × Clear all
NCT07582003 2026-05-12

A Phase I Trial of S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas

Cedars-Sinai Medical Center

Phase 1 Not yet recruiting
18 enrolled
Gastrointestinal

Adenoma, Disease, Colorectal Neoplasms

NCT06258525 2026-05-06

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Cedars-Sinai Medical Center

Phase 2 Not yet recruiting
30 enrolled
Classical hematologyGastrointestinal

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

NCT07495995 2026-03-31

SAMeMASLDc-02

Cedars-Sinai Medical Center

Phase 2 Not yet recruiting
94 enrolled

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡